| Mrs Sarah Catherine Tucker, OTR/L | |
|
1600 7th Ave S, Birmingham, AL 35233-1711 | |
| (205) 939-9645 | |
| (205) 969-6067 |
| Full Name | Mrs Sarah Catherine Tucker |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Pediatrics |
| Location | 1600 7th Ave S, Birmingham, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104059435 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | 2574 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Sarah Catherine Tucker, OTR/L 1600 7th Ave S, Birmingham, AL 35233-1711 Ph: (205) 939-9645 | Mrs Sarah Catherine Tucker, OTR/L 1600 7th Ave S, Birmingham, AL 35233-1711 Ph: (205) 939-9645 |
News Archive
While the data reveal a substantial financial widowhood penalty among all ethnic groups, minority women often have lower incomes and fewer assets to begin with.
Array BioPharma Inc. today announced the presentation of positive Phase 1 clinical data for its novel kinesin spindle protein inhibitor, ARRY-520. The data, which were presented at the 2010 Annual Meeting of the American Society of Hematology in Orlando, Florida, indicate that ARRY-520 was well tolerated and has shown encouraging preliminary results in the treatment of multiple myeloma.
Emergent BioSolutions Inc. announced today that it has closed on its acquisition of Bracco Diagnostics Inc.'s Healthcare Protective Products Division. This acquisition, which includes the RSDL (decontamination lotion) product that is cleared for marketing by the U.S. Food and Drug Administration for removal or neutralization of chemical warfare agents from the skin, diversifies and broadens Emergent's biodefense franchise into the chemical countermeasure market.
Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.
› Verified 5 days ago
Mccall Henger Christenson, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1600 5th Ave S, Birmingham, AL 35233 Phone: 205-939-9100 | |
Joseph Chase Bennett, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 700 South 19th Street, 8305a - Office, Birmingham, AL 35233 Phone: 205-933-8101 | |
Lynn Paige Larkey, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1600 7th Ave S, Pt/ot Dept 4nw, Birmingham, AL 35233 Phone: 205-939-9645 Fax: 205-939-6067 | |
Mrs. Margiean Bridget Burks, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1600 5th Ave S, Birmingham, AL 35233 Phone: 205-939-6296 Fax: 205-558-2077 | |
Candace C Davis, O.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 930 20th St S, Suite 101, Birmingham, AL 35205 Phone: 205-934-5471 Fax: 205-975-2380 | |
Mrs. Anne Nehlig Walker, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4778 Overton Rd, Birmingham, AL 35210 Phone: 205-957-0294 Fax: 205-957-0298 | |
Anna Layne Wood, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4778 Overton Rd, Birmingham, AL 35210 Phone: 205-957-0294 Fax: 205-957-0298 |